LIFE
LIFE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
3
$10.00M
Insider Sales
26
$94.90M
Total Volume
$104.90M
46 transactions
Net Activity
$84.90M
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 90% of total transaction value.
- •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •High accumulation: total purchase value exceeds $1M.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale+OE Insiders
$67.87B total
Gv 2017 Gp, L.L.C.
10%
$35.06M total
Gv 2019 Gp, L.L.C.
10%
$15.13M total
Wang Lingke
Pres
$14.89M total
Colis Peter George
CEO, Secretary
$12.43M total
Quick Actions
LIFE has an insider buy conviction of 10%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at LIFE (LIFE) engaged in a total of 46 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 26 were sales. The total volume of insider trading reached $104.90M.
The net insider activity for LIFE shows a net selling bias of $84.90M. This activity represents a 10% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 260.5K shares valued at $67.87B on Jan 29, 2026.
Anthropic IPO Live: Stock Closes Day At $97—Up More Than 17%
Could $1,000 in Oklo Stock Set You Up for Life by 2035?
SELLAS Life Sciences Prices $150 Million Stock Offering at $13 Per Share
Sellas Life Sciences Stock Triples After Cancer Vaccine Data
SELLAS Life Sciences Group Stock After Phase 3 Win And $150 Million Share Sale
Are Wall Street Analysts Bullish on Globe Life’s Stock?
Related News & Analyst Reports
Read original insights and educational research covering LIFE and the Unknown sector.
FAQs About LIFE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for LIFE.